Literature DB >> 31632755

Postoperative management of lung transplant recipients.

Christina C Kao1, Amit D Parulekar1.   

Abstract

Despite advances in surgical technique, lung transplantation is associated with worse survival when compared with other solid organ transplantations. Graft dysfunction and infection are the leading causes of mortality in the first 30 days following transplantation. Primary graft dysfunction (PGD) is a form of reperfusion injury that occurs early after transplantation. Management of PGD is mainly supportive with use of lung protective ventilation. Inhaled nitric oxide (iNO) and extracorporeal membrane oxygenation may be used in severe cases. Bacterial pneumonias are the most common infectious complication in the immediate post transplant period, but invasive fungal infections may also occur. Other potential complications in the postoperative period include atrial arrhythmias and neurologic complications such as stroke. There is a lack of multicenter, randomized trials to guide ventilation strategies, infection prophylaxis, and treatment of atrial arrhythmias, therefore prevention and management of post-transplant complications vary by transplant center. 2019 Journal of Thoracic Disease. All rights reserved.

Entities:  

Keywords:  Primary graft dysfunction (PGD); arrhythmia; ventilation

Year:  2019        PMID: 31632755      PMCID: PMC6783721          DOI: 10.21037/jtd.2019.05.60

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  47 in total

1.  Atrial arrhythmias after lung transplant: underlying mechanisms, risk factors, and prognosis.

Authors:  Carlos M Orrego; Andrea M Cordero-Reyes; Jerry D Estep; Harish Seethamraju; Scott Scheinin; Matthias Loebe; Guillermo Torre-Amione
Journal:  J Heart Lung Transplant       Date:  2014-03-04       Impact factor: 10.247

Review 2.  Adverse outcomes associated with postoperative atrial arrhythmias after lung transplantation: A meta-analysis and systematic review of the literature.

Authors:  Nathan H Waldron; Rebecca Y Klinger; Matthew G Hartwig; Laurie D Snyder; James P Daubert; Joseph P Mathew
Journal:  Clin Transplant       Date:  2017-03-14       Impact factor: 2.863

3.  The effect of primary graft dysfunction on survival after lung transplantation.

Authors:  Jason D Christie; Robert M Kotloff; Vivek N Ahya; Gregory Tino; Alberto Pochettino; Christina Gaughan; Ejigayehu DeMissie; Stephen E Kimmel
Journal:  Am J Respir Crit Care Med       Date:  2005-03-11       Impact factor: 21.405

4.  Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.

Authors:  David J Lederer; Steven M Kawut; Nancy Wickersham; Christopher Winterbottom; Sangeeta Bhorade; Scott M Palmer; James Lee; Joshua M Diamond; Keith M Wille; Ann Weinacker; Vibha N Lama; Maria Crespo; Jonathan B Orens; Joshua R Sonett; Selim M Arcasoy; Lorraine B Ware; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

5.  Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.

Authors:  Shiraz A Daud; Roger D Yusen; Bryan F Meyers; Murali M Chakinala; Michael J Walter; Aviva A Aloush; G Alexander Patterson; Elbert P Trulock; Ramsey R Hachem
Journal:  Am J Respir Crit Care Med       Date:  2006-12-07       Impact factor: 21.405

6.  Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation.

Authors:  I Adatia; C Lillehei; J H Arnold; J E Thompson; R Palazzo; J C Fackler; D L Wessel
Journal:  Ann Thorac Surg       Date:  1994-05       Impact factor: 4.330

7.  Inhaled nitric oxide for modulation of ischemia-reperfusion injury in lung transplantation.

Authors:  Phil Botha; Mylvaganam Jeyakanthan; Jagan N Rao; Andrew J Fisher; Mahesh Prabhu; John H Dark; Steven C Clark
Journal:  J Heart Lung Transplant       Date:  2007-11       Impact factor: 10.247

8.  Hyperammonemia Syndrome After Lung Transplantation: A Single Center Experience.

Authors:  Catherine Chen; Karen B Bain; Jennifer A Iuppa; Roger D Yusen; Derek E Byers; George A Patterson; Elbert P Trulock; Ramsey R Hachem; Chad A Witt
Journal:  Transplantation       Date:  2016-03       Impact factor: 4.939

9.  Atrial fibrillation after pulmonary transplant.

Authors:  Thomas D Nielsen; Tristram Bahnson; R Duane Davis; Scott M Palmer
Journal:  Chest       Date:  2004-08       Impact factor: 9.410

10.  Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: analysis of the Extracorporeal Life Support Organization (ELSO) registry.

Authors:  Stefan Fischer; Desmond Bohn; Peter Rycus; Andrew F Pierre; Marc de Perrot; Thomas K Waddell; Shaf Keshavjee
Journal:  J Heart Lung Transplant       Date:  2007-05       Impact factor: 10.247

View more
  5 in total

Review 1.  Review of outcomes of delayed chest closure following lung transplantation: a meta-analysis.

Authors:  Cheng Chen; Quan Zheng; Dongsheng Wu; Yongxiang Song; Gang Xu
Journal:  J Cardiothorac Surg       Date:  2022-05-19       Impact factor: 1.522

2.  The prognostic value of peak arterial lactate levels within 72 h of lung transplantation in identifying patient outcome.

Authors:  Jingjing Xu; Zhong Qin; Yanjuan Wang; Chunxiao Hu; Guilong Wang; Zhengfeng Gu; Shengjie Yuan; Jingyu Chen; Dongxiao Huang; Zhiping Wang
Journal:  J Thorac Dis       Date:  2020-12       Impact factor: 2.895

3.  Metagenomic Next-Generation Sequencing for Diagnosing Infections in Lung Transplant Recipients: A Retrospective Study.

Authors:  Chun-Rong Ju; Qiao-Yan Lian; Wei-Jie Guan; Ao Chen; Jian-Heng Zhang; Xin Xu; Rong-Chang Chen; Shi-Yue Li; Jian-Xing He
Journal:  Transpl Int       Date:  2022-02-10       Impact factor: 3.782

4.  Critical Care Management Following Lung Transplantation.

Authors:  Kyeongman Jeon
Journal:  J Chest Surg       Date:  2022-08-05

5.  Population Pharmacokinetics of Caspofungin among Extracorporeal Membrane Oxygenation Patients during the Postoperative Period of Lung Transplantation.

Authors:  Qianlin Wang; Zhu Zhang; Donglin Liu; Wenqian Chen; Gang Cui; Pengmei Li; Xianglin Zhang; Min Li; Qingyuan Zhan; Chen Wang
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.